AstraZeneca's COVID-19 vaccine offers stronger immunity with 45-week gap between doses, company says

[Admin]

A longer, 10-month delay in administering second doses of AstraZeneca’s COVID-19 vaccine afforded trial participants stronger immunity, the company announced Monday, aiming to assuage concerns of compromised immunity among populations of countries with short vaccine supply.

View the full article